
Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs. The company’s first product is the Lumicell Direct Visualization System, designed to provide real-time illumination of cancerous tissue within the breast cavity during the initial lumpectomy, potentially reducing repeat surgeries. Lumicell’s proprietary, pan-oncologic optical imaging agent is also being explored across a wide variety of solid tumor indications. The company aims to enhance the standard of care treatment by guiding the resection of additional cancer that may have otherwise been left behind.
51 - 200 employees
💰 $28.7M Series C on 2017-10
November 23
51 - 200
Strategic Account Manager at Lumicell driving sales for innovative cancer surgery solutions. Establishing key relationships and exceeding quota expectations in the Northeast territory.